Pharmacological evaluation of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent

X De Leval, T Dassesse, V Benoit, Bernard Pirotte, Jean-Louis David, Marie-Paule Merville, Vincenzo Castronovo, Jean-Michel Dogné

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
JournalBlood
Publication statusPublished - 2003

Cite this